Skip to content
10-Q

Quarterly Report

Traws Pharma, Inc. TRAW

0001104659-26-061779

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 12, 2026 15.15M sh
Shares Diluted Q1 2026 · Mar 31, 2026 10.64M sh
Shares Diluted Q1 2026 · Mar 31, 2025 7.22M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$2.58M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$5.44M
Current Liabilities Q1 2026 · Mar 31, 2026 $13.21M
Current Liabilities Q1 2026 · Dec 31, 2025 $11.15M
Total Liabilities Q1 2026 · Mar 31, 2026 $13.47M
Total Liabilities Q1 2026 · Dec 31, 2025 $11.25M
Current Assets Q1 2026 · Mar 31, 2026 $5.67M
Current Assets Q1 2026 · Dec 31, 2025 $7.98M
Total Assets Q1 2026 · Mar 31, 2026 $8.16M
Total Assets Q1 2026 · Dec 31, 2025 $10.62M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.53
Eps Diluted Q1 2026 · Mar 31, 2025 $2.09
Eps Basic Q1 2026 · Mar 31, 2026 −$0.53
Eps Basic Q1 2026 · Mar 31, 2025 $2.17
Sga Expense Q1 2026 · Mar 31, 2026 $2.03M
Sga Expense Q1 2026 · Mar 31, 2025 $2.75M
Rd Expense Q1 2026 · Mar 31, 2026 $4.91M
Rd Expense Q1 2026 · Mar 31, 2025 $2.51M
Net Income Q1 2026 · Mar 31, 2026 −$7.11M
Net Income Q1 2026 · Mar 31, 2025 $21.49M
Operating Income Q1 2026 · Mar 31, 2026 −$6.95M
Operating Income Q1 2026 · Mar 31, 2025 −$5.2M